Trishula Therapeutics

Trishula Therapeutics is a privately held, clinical-stage immuno-oncology company developing cancer immunotherapies that target immune-evasion mechanisms in the tumor microenvironment. Its lead candidate, TTX-030, is a first-in-class monoclonal antibody that inhibits CD39, an enzyme in the adenosine pathway that tumors exploit to suppress anti-tumor immunity; TTX-030 has advanced into Phase 2 clinical trials, including studies in metastatic pancreatic cancer. The company was surfaced through the API Evangelist network as a portfolio company of Canaan Partners. It is a therapeutics company with a corporate web presence and no public API, developer, or software product surface.

Trishula Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Immuno-Oncology, Pharmaceuticals, and Cancer.

Trishula Therapeutics’ developer surface includes engineering blog and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub
7.2/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechnologyImmuno-OncologyPharmaceuticalsCancerTherapeuticsClinical StageImmunotherapy

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 7.2/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/trishula-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Trishula Therapeutics Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 4

The organization behind the API

Website
Website
 About
About
 Blog
Blog
 LinkedIn
LinkedIn

Source (apis.yml)

apis.yml Raw ↑ 
aid: trishula-therapeutics
name: Trishula Therapeutics
description: Trishula Therapeutics is a privately held, clinical-stage immuno-oncology company developing cancer immunotherapies
  that target immune-evasion mechanisms in the tumor microenvironment. Its lead candidate, TTX-030, is a first-in-class monoclonal
  antibody that inhibits CD39, an enzyme in the adenosine pathway that tumors exploit to suppress anti-tumor immunity; TTX-030
  has advanced into Phase 2 clinical trials, including studies in metastatic pancreatic cancer. The company was surfaced through
  the API Evangelist network as a portfolio company of Canaan Partners. It is a therapeutics company with a corporate web
  presence and no public API, developer, or software product surface.
url: https://raw.githubusercontent.com/api-evangelist/trishula-therapeutics/refs/heads/main/apis.yml
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://www.trishulatx.com/themes/default/images/logo.svg
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Biotechnology
- Immuno-Oncology
- Pharmaceuticals
- Cancer
- Therapeutics
- Clinical Stage
- Immunotherapy
apis: []
common:
- type: DomainSecurity
  url: security/trishula-therapeutics-domain-security.yml
- type: Website
  url: https://www.trishulatx.com
- type: About
  url: https://www.trishulatx.com/about/
- type: Blog
  name: News
  url: https://www.trishulatx.com/news/
- type: LinkedIn
  url: https://www.linkedin.com/company/trishulatx/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 1
  pass: local-v1